Search clinical trials for: HA22
Total 14 results
-
AstraZenecaApproved for marketingRelapsed/Refractory Hairy Cell Leukemia
-
Cambridge Antibody TechnologyUnknownLeukemia | Hairy Cell Leukemia | HCLUnited States, Poland, United Kingdom
-
Cambridge Antibody TechnologyUnknownLeukemiaUnited States, Poland
-
Center for International Blood and Marrow Transplant...MedImmune LLC; National Marrow Donor Program; Pediatric Blood and Marrow Transplant... and other collaboratorsTerminatedAcute Lymphoblastic Leukemia (ALL)United States
-
MedImmune LLCNational Cancer Institute (NCI)CompletedNon-Hodgkin's Lymphoma | Acute Lymphoblastic LeukemiaUnited States, Canada
-
MedImmune LLCCambridge Antibody TechnologyTerminatedLeukemia, Lymphoma, Chronic Lymphocytic | Leukemia, Prolymphocytic Leukemia, Small | Lymphocytic Lymphoma, Moxetumomab PasudotoxUnited States, Poland
-
MedImmune LLCTerminatedLymphomaUnited States, Poland
-
MedImmune LLCTerminatedB-Cell Pediatric ALLUnited States, Australia, France, Spain, Canada, Netherlands, United Kingdom, Italy
-
MedImmune LLCCambridge Antibody TechnologyCompletedHairy Cell LeukemiaUnited States, Poland
-
MedImmune LLCCompletedLeukemia, Hairy CellItaly, Spain, United States, Belgium, Poland, Czechia, Germany, Serbia, United Kingdom, France, Israel, Ireland, Canada, Norway
-
M.D. Anderson Cancer CenterMedImmune LLCTerminated
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Poland
-
Cambridge Antibody TechnologyUnknownLeukemia | Non-Hodgkin's Lymphoma | NHLUnited States, Poland
-
National Cancer Institute (NCI)Active, not recruitingHairy Cell LeukemiaUnited States